Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of ZTI-01 on ECG in Healthy Adults
NCT03709927Phase 1Completed
- Sponsor
- Nabriva Therapeutics plc
- Start
- Jan 2018
- Primary completion
- Apr 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of fosfomycin disodium in complicated urinary tract infection (cUTI) and acute pyelonephritis (4 arms), sponsored by Nabriva Therapeutics plc. Primary endpoint: Effect of ZTI-01 on cardiac repolarization expressed by QT interval at 24 hours. Started Jan 2018; status: completed.
02
Drugs
fosfomycin disodium
03
Conditions
complicated urinary tract infection (cUTI)acute pyelonephritis
Beyond the preview
Go deeper on NCT03709927.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03709927.